Shanghai-based Fosun Pharmaceutical Group, the promoter of Gland Pharma in India, plans to sell up to a 5% stake in the company through a block deal to raise ₹1,435 crore ($172 million), according to a term sheet...
Suven Pharma to acquire controlling stake in Hyderabad-based CDMO Sapala Organic
PE firm Advent International backed Suven Pharmaceuticals said it has entered into a definitive agreement to acquire a controlling stake in Hyderabad-based contract research development organisation (CDMO) Sapala...
ChrysCapital sets sights on pharma buyout deals
Homegrown private equity firm ChrysCapital is looking to acquire domestic companies in the formulation business in the range of $200 million-$500 million. Along with partners, deal sizes can potentially reach $1.5...
Sun Pharma to pursue M&A, licensing to expand speciality business
Sun Pharma, India’s largest drug maker, will pursue licensing and acquisitions to expand its speciality business, the company’s senior executive said. “M&A – we have always tried to be very...
Taro shareholders approve merger with Sun Pharma
Shareholders of Taro have approved the company’s merger agreement with Sun Pharma, the Mumbai-based drug major said on Thursday. The merger agreement between Israel-based Taro and Sun Pharma was approved by the...
Local pharma companies queue up for JB Chemicals & Pharmaceuticals
Mankind Pharma, Dr Reddy’s Laboratories and Torrent Pharma are among those that have evinced interest in acquiring JB Chemicals & Pharmaceuticals from KKR, said multiple people aware of the development. A few large...
Novo Nordisk owner buys majority stake in Austrian life science tools company
Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it would buy a controlling stake of about 60% in Single Use Support, an Austria-based life science tools company. It...
Cipla promoters to sell up to 2.53% for Rs 2,637 crore
Some members of the Hamied family that founded Cipla are set to offload shares via block deals, said people aware of the matter, eight months after promoter-stake-sale talks with Torrent Pharma collapsed. A stake of up...
Bayer acquires remaining 25% stake in Bayer Zydus Pharma Pvt Ltd to secure full ownership
Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited (formerly Cadila Healthcare) on Thursday announced the conclusion of their joint venture (JV) – Bayer Zydus Pharma Private Limited (BZPPL). The...
Novartis to buy radiology drug specialist Mariana for $1 billion
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug manufacturer said on Thursday...
Japan’s Ono to buy US drugmaker Deciphera for $2.4 bln
Deciphera Pharmaceuticals said on Monday Japan’s Ono Pharmaceutical Co will acquire the cancer drugmaker for $2.4 billion to expand its oncology portfolio and presence in the United States and Europe. Ono Pharma...
CVC explores options for Italy’s Recordati, Bloomberg News reports
CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA, Bloomberg News reported on Tuesday, citing people familiar with the matter. CVC is working with advisers...
